TAM-16

N/A

Report date: 2023/03/13 11:26:20
NME

Base Information

Drug NameTAM-16
Drug Alias NameTAM-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolyketide synthase Pks13 inhibitors
TargetsPolyketide synthase Pks13
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University
China Registration ClassN/A

Develop Information

Active CompaniesTexas A&M University
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A